CLINICAL_TRIALS trial_result · 2016-05-09

Clinical Trial Update: Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation [Phase 3]

Safety and tolerability data from a Phase 3 extension trial in patients with Chronic Idiopathic Constipation, sponsored by Ferring Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ferring Pharmaceuticals | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2016-05-09